ZA755614B - 1,3,4-trisubstituted-4-arylpiperidines and their preparation - Google Patents

1,3,4-trisubstituted-4-arylpiperidines and their preparation

Info

Publication number
ZA755614B
ZA755614B ZA755614A ZA755614A ZA755614B ZA 755614 B ZA755614 B ZA 755614B ZA 755614 A ZA755614 A ZA 755614A ZA 755614 A ZA755614 A ZA 755614A ZA 755614 B ZA755614 B ZA 755614B
Authority
ZA
South Africa
Prior art keywords
arylpiperidines
trisubstituted
preparation
Prior art date
Application number
ZA755614A
Other languages
English (en)
Inventor
D Zimmerman
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of ZA755614B publication Critical patent/ZA755614B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/70—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/20—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/10—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms
    • C07D211/14—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms with hydrocarbon or substituted hydrocarbon radicals attached to the ring nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/20—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
    • C07D211/22—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Addiction (AREA)
  • Psychiatry (AREA)
  • Toxicology (AREA)
  • Pain & Pain Management (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
ZA755614A 1974-09-06 1975-09-03 1,3,4-trisubstituted-4-arylpiperidines and their preparation ZA755614B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US50358174A 1974-09-06 1974-09-06

Publications (1)

Publication Number Publication Date
ZA755614B true ZA755614B (en) 1977-04-27

Family

ID=24002675

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA755614A ZA755614B (en) 1974-09-06 1975-09-03 1,3,4-trisubstituted-4-arylpiperidines and their preparation

Country Status (27)

Country Link
US (1) US4081450A (ja)
JP (3) JPS5929588B2 (ja)
AR (1) AR206937A1 (ja)
AT (1) AT350567B (ja)
BE (1) BE833044A (ja)
BG (2) BG24950A3 (ja)
CA (1) CA1069901A (ja)
CH (1) CH625787A5 (ja)
CS (1) CS188237B2 (ja)
DD (1) DD121636A5 (ja)
DE (1) DE2539452A1 (ja)
DK (1) DK153397C (ja)
ES (1) ES440771A1 (ja)
FR (2) FR2283679A1 (ja)
GB (1) GB1525584A (ja)
HU (1) HU173057B (ja)
IE (1) IE41610B1 (ja)
IL (1) IL48003A (ja)
NL (1) NL7510535A (ja)
NZ (1) NZ178501A (ja)
PH (2) PH12618A (ja)
PL (3) PL117501B1 (ja)
RO (1) RO68142A (ja)
SE (1) SE425489B (ja)
SU (2) SU629875A3 (ja)
YU (2) YU221675A (ja)
ZA (1) ZA755614B (ja)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4284635A (en) * 1978-11-29 1981-08-18 Eli Lilly And Company Analgesic 1,2,4,5-tetra-alkyl-4-arylpiperidines
FR2451368A1 (fr) * 1979-03-12 1980-10-10 Lilly Co Eli Phenylmorphanes, intermediaires et procedes de synthese, et leur utilisation therapeutique
ZA813127B (en) * 1980-05-13 1982-05-26 May & Baker Ltd A new phenylpropargylamine derivative
CH646696A5 (de) 1980-11-28 1984-12-14 Sandoz Ag Dibenzazepine, ihre herstellung und verwendung.
FR2518093A2 (fr) * 1980-12-15 1983-06-17 Roussel Uclaf Nouveaux derives de l'hydroxyphenyl tetrahydropyridine, leurs sels, procede et intermediaires de preparation, application a titre de medicaments et compositions les renfermant
US4581456A (en) * 1983-09-21 1986-04-08 Eli Lilly And Company Processes for preparing picenadol precursors and novel intermediates thereof
US4931558A (en) * 1983-09-21 1990-06-05 Eli Lilly And Company Processes for preparing intermediates of picenadol
US4678638A (en) * 1985-07-24 1987-07-07 Petrolite Corporation Highly branched amino hexahydropyridines
NZ224236A (en) * 1987-04-16 1990-08-28 Lilly Co Eli Trans 3,4 pyridine derivatives and pharmaceutical compositions
US5319087A (en) * 1987-04-16 1994-06-07 Eli Lilly And Company Piperidine opioid antagonists
EP0299549A3 (en) * 1987-07-09 1989-02-08 Duphar International Research B.V Tertiary 2,5-dialkyl-3-phenyl-piperidine derivatives having opiate-antagonistic activity
US5250542A (en) * 1991-03-29 1993-10-05 Eli Lilly And Company Peripherally selective piperidine carboxylate opioid antagonists
US5270328A (en) * 1991-03-29 1993-12-14 Eli Lilly And Company Peripherally selective piperidine opioid antagonists
US5159081A (en) * 1991-03-29 1992-10-27 Eli Lilly And Company Intermediates of peripherally selective n-carbonyl-3,4,4-trisubstituted piperidine opioid antagonists
ZA9610741B (en) * 1995-12-22 1997-06-24 Warner Lambert Co 4-Substituted piperidine analogs and their use as subtype selective nmda receptor antagonists
GB9725114D0 (en) * 1997-11-28 1998-01-28 Pfizer Ltd Treatment of pruritus
GB9810671D0 (en) 1998-05-18 1998-07-15 Pfizer Ltd Anti-pruritic agents
GB9912415D0 (en) 1999-05-28 1999-07-28 Pfizer Ltd Compounds useful in therapy
GB9912413D0 (en) 1999-05-28 1999-07-28 Pfizer Ltd Compounds useful in therapy
GB9912411D0 (en) * 1999-05-28 1999-07-28 Pfizer Ltd Compounds useful in therapy
GB9912410D0 (en) 1999-05-28 1999-07-28 Pfizer Ltd Compounds useful in therapy
GB9912416D0 (en) 1999-05-28 1999-07-28 Pfizer Ltd Compounds useful in therapy
GB9912417D0 (en) 1999-05-28 1999-07-28 Pfizer Ltd Compounds useful in therapy
US7045527B2 (en) * 2002-09-24 2006-05-16 Amgen Inc. Piperidine derivatives
US10519111B2 (en) 2013-07-15 2019-12-31 Coral Sunscreen Pty Ltd UV absorbing compounds, compositions comprising same and uses thereof
WO2015006803A1 (en) * 2013-07-15 2015-01-22 Coral Sunscreen Pty Ltd Uv absorbing compounds, compositions comprising same and uses thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DD87036A (ja) *
US2892842A (en) * 1959-06-30 Their preparation
US2075359A (en) * 1930-10-16 1937-03-30 Du Pont Insecticide
US1915334A (en) * 1930-10-16 1933-06-27 Du Pont Fluosilicate of organic heterocyclic bases and process of making it
US3080372A (en) * 1960-03-25 1963-03-05 Res Lab Dr C Janssen 1-aroylalkyl-4-arylpiperidine derivatives
US3936468A (en) * 1969-10-27 1976-02-03 Sumitomo Chemical Company, Ltd. Phenylbutanol derivatives

Also Published As

Publication number Publication date
NZ178501A (en) 1978-09-20
BG24802A3 (en) 1978-05-12
GB1525584A (en) 1978-09-20
CS188237B2 (en) 1979-02-28
YU233681A (en) 1982-02-28
JPS5916875A (ja) 1984-01-28
IL48003A (en) 1981-01-30
DK153397B (da) 1988-07-11
JPS6051174A (ja) 1985-03-22
PL100438B1 (pl) 1978-10-31
IL48003A0 (en) 1975-11-25
BG24950A3 (en) 1978-06-15
DD121636A5 (ja) 1976-08-12
DK153397C (da) 1988-12-05
DK397575A (da) 1976-03-07
CH625787A5 (ja) 1981-10-15
RO68142A (ro) 1981-08-30
CA1069901A (en) 1980-01-15
JPS6012350B2 (ja) 1985-04-01
SU629875A3 (ru) 1978-10-25
AU8431375A (en) 1977-03-03
PL108465B1 (en) 1980-04-30
NL7510535A (nl) 1976-03-09
SE7509640L (sv) 1976-03-08
US4081450A (en) 1978-03-28
PH14016A (en) 1980-12-08
ES440771A1 (es) 1977-04-01
FR2299337A1 (fr) 1976-08-27
JPS5148670A (ja) 1976-04-26
JPS6026782B2 (ja) 1985-06-25
FR2283679B1 (ja) 1979-09-14
BE833044A (fr) 1976-03-03
FR2299337B1 (ja) 1979-01-19
HU173057B (hu) 1979-02-28
YU221675A (en) 1982-02-28
IE41610L (en) 1976-03-06
SU621316A3 (ru) 1978-08-25
AR206937A1 (es) 1976-08-31
PL117501B1 (en) 1981-08-31
ATA685275A (de) 1978-11-15
JPS5929588B2 (ja) 1984-07-21
AT350567B (de) 1979-06-11
PH12618A (en) 1979-07-05
DE2539452A1 (de) 1976-03-18
FR2283679A1 (fr) 1976-04-02
SE425489B (sv) 1982-10-04
IE41610B1 (en) 1980-02-13

Similar Documents

Publication Publication Date Title
ZA755614B (en) 1,3,4-trisubstituted-4-arylpiperidines and their preparation
ZA751193B (en) 1,1-diaryl-1-oxadiazol-alkylamines
IL47535A0 (en) 7-methoxy-6-thiatetracyclines and their preparation
ZA755929B (en) Aminobenzazocines and preparation thereof
ZA753355B (en) New biguanides and the preparation thereof
IL48572A (en) 8,8-disubstituted-6-methylergolines and related compounds
ZA754042B (en) 9-thia- or oxothia and dioxothia-11,12-seco-prostaglandin
ATA392274A (de) Einrichtung zum antrieb einer durchbiegungsausgleichwalze
IL47335A0 (en) Hexahydro-diazepino-indole derivatives and the preparation thereof
GB1521487A (en) 1,2,3,4-tetrahydroisoquinolines and the preparation thereof
IL48002A0 (en) 5-cyanoalkyl-1,3,4-thiadiazole-2-ylureas
IL48140A0 (en) Novel 2,6-methano-3-benzazocines and their preparation
IL49823A0 (en) 1-acyl-1,2,3,4-tetrahydro-6-quinolinols and their preparation
ZA745608B (en) 3,3-methylene-bis-(4-hydroxy-5-azacoumarin) its preparation and use
IL47487A (en) 9-thia-or oxothia-and diocxothia-11,12-seco and 11-nor-11,12-seco-prostaglandins
IL47111A (en) 3,4-dicarboxycephalosporins and derivatives
ZA752349B (en) New nitroimidazolyl-triazolo-pyridazines and the preparation thereof
EG12408A (en) O,s-dialkyl o-sulfonyloxyphenyl phosphoro-thiolates and phosphorodithiates
ZA756355B (en) 3,7-dimethyl-3-hydroxy-6-octenenitrile and process for its preparation
GB1486847A (en) Carboxy-cyproheptadines their preparation and use
IE41250B1 (en) 2,2-bis-hydroxymethylalkanesulphonates
AU491809B2 (en) 1, 3, 4-trisubstituted-4-phenylpiperidines and their preparation
PH13018A (en) 1,2,4-triazolidin-2-ones
NZ184437A (en) 9-formyl-9 10-hihydro-9,10-methanoanthrancene and the preparation thereof
IE40508B1 (en) -thiolincosaminides and the preparation thereof